Glen Novarro

Medical device and supplies manufacturer Abbott Laboratories (NYSE: ABT)reported Wednesday ahead of the market open with above-consensus fourth-quarter earnings, while revenue trailed expectations. The Analysts RBC Capital Markets analyst Glen Novarro reiterated an Outperform rating...